We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GPN:NYSEGlobal Payments Inc. Analysis

Data as of 2026-05-27 - not real-time

$75.06

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Global Payments is trading around $75, just below the identified resistance of $75.6 and modestly above the 20‑day SMA (≈$70.3) while the 50‑day SMA sits near $69.2, suggesting a short‑term price cushion. The RSI of 66.8 hints at near‑overbought conditions, yet the MACD remains bullish with a widening histogram, and the overall trend is neutral despite a decreasing volume trend.
Fundamentally, the company posted $8.86 B in revenue with a striking 63% YoY growth, solid gross margins (~67%) and an operating margin of ~12.5%, though net profit margin is currently negative. The DCF‑derived fair value of roughly $863 implies an upside of over 26%, while the forward PE of 4.6x and a low price‑to‑book of 0.86 underscore significant undervaluation. A dividend yield of 1.36% with a payout ratio under 40% appears sustainable, and analyst consensus remains a “Buy.” Recent earnings beat and strategic AI‑driven product expansions, coupled with continued ownership by Glenview Capital, provide additional bullish catalysts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near technical resistance
  • Bullish MACD but RSI approaching overbought
  • Decreasing volume suggesting caution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and expanding AI‑driven offerings
  • Undervalued valuation metrics (forward PE ~4.6x, P/B <1)
  • Analyst consensus of Buy and continued institutional ownership

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Long‑term upside potential from DCF fair value gap
  • Strategic positioning in global payment ecosystems and AI integration

Key Metrics & Analysis

Financial Health

Revenue Growth63.10%
Profit Margin-7.97%
P/E Ratio27.6
ROE2.94%
ROA2.37%
Debt/Equity95.59
P/B Ratio0.9
Op. Cash Flow$1.8B
Free Cash Flow$7.1B
Industry P/E30.1

Technical Analysis

TrendNeutral
RSI66.8
Support$66.13
Resistance$75.60
MA 20$70.32
MA 50$69.18
MA 200$77.27
MACDBullish
VolumeDecreasing
Fear & Greed Index91.29

Valuation

Fair Value$863.00
Target Price$94.92
Upside/Downside26.46%
GradeUndervalued
TypeGrowth
Dividend Yield1.36%

Risk Assessment

Beta1.32
Volatility31.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.